Christopher F. Wyatt - 31 Jan 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Controller
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
31 Jan 2024
Transactions value $
-$813,950
Form type
4
Filing time
02 Feb 2024, 18:53:40 UTC
Previous filing
22 Feb 2023
Next filing
07 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $220K +2.68K +7.43% $81.96 38.8K 31 Jan 2024 Direct
transaction HCA Common Stock Options Exercise $910K +9K +23.22% $101.16 47.8K 31 Jan 2024 Direct
transaction HCA Common Stock Tax liability -$1.94M -6.38K -13.35% $304.90 41.4K 31 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -2.68K -100% $0.00* 0 31 Jan 2024 Common Stock 2.68K $81.96 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -9K -49.18% $0.00 9.3K 31 Jan 2024 Common Stock 9K $101.16 Direct F2
transaction HCA Stock Appreciation Right Award $0 +4.4K $0.00 4.4K 31 Jan 2024 Common Stock 4.4K $304.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
F3 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.